Expert Directory

Jason R. Dwyer, PhD

Associate Professor of Chemistry

University of Rhode Island

Chemistry, Nanoscience, Biophysical Chemistry, materials science

In the quest for molecular-level information, molecular-scale tools are a powerful and desirable scientific goal. Our research program is centered on development of a new class of nanofabricated devices based on nanopores.

In its simplest form, a nanopore is nothing more than a molecular-sized hole in an insulating membrane. Yet even in this configuration, it is cable of being used to detect and manipulate single molecules. With careful device engineering, it is possible to create powerful sensors for the detection of disease biomarkers at low levels early in the onset of disease or of trace amounts of toxins -- to name two targets. Configured differently, nanopore-based devices can be used to probe intermolecular interactions that underpin biological function -- ranging from testing new pharmaceutical drug candidates to exploring the fundamental biophysics governing processes such as antibody-antigen recognition.

Our research is focused on conceiving, fabricating and optimizing the nanopore devices that will make possible these challenging goals.

Research Interests include:

How do molecules work, and how can we better put them to work for us? Bioanalytical, biophysical, & materials chemistry and nanoscience.

Rebecca Edelmayer, PhD

Director, Scientific Engagement

Alzheimer's Association

medical pharmacology, Neuropharmacology, pain neurobiology, inflammatory skin pathology

Dr. Edelmayer leads efforts to accelerate the scientific agenda of the Alzheimer’s Association through the creation and delivery of ongoing research education. She engages with more than 75 Alzheimer’s Association chapters across the country, ensuring that staff and the public are aware of the importance of medical research and the Association’s crucial role in advancing research to improve the lives of individuals living with dementia and their care partners. In addition, Dr. Edelmayer manages initiatives uniting researchers and clinicians with leaders of industry, regulatory agencies and the government on topics related to blood-based biomarker testing, use of digital health technologies and biotech approaches in studying dementia.

Dr. Edelmayer has over 17 years of experience as a practicing scientist and educator. She spent more than six years as a pharmacologist in the Neuroscience and Immunology Discovery Divisions at Abbott and AbbVie, where she was recognized as an emerging scientific leader. As a senior scientist, she led a digital pathology team, conducted research and supported the development of clinical therapeutics in chronic inflammatory diseases of the nervous system and the skin. Dr. Edelmayer has lectured, published and led collaborations in areas of neurophysiology, inflammatory skin pathology and pain neurobiology.

She completed her Ph.D. and postdoctoral training in medical pharmacology with a focus on neuropharmacology at the University of Arizona College of Medicine. Dr. Edelmayer holds a bachelor’s degree in neuroscience from the University of Pittsburgh, where she also completed a National Institute of Mental Health Research Fellowship. 

Stephen Edge, MD

Vice President for Healthcare Outcomes and Policy

Roswell Park Comprehensive Cancer Center

Breast Cancer, Breast Cancer Surgery, Surgery, cancer incidence, Health Care Delivery, Health Care Outcomes

Vice President for Healthcare Outcomes and Policy, Roswell Park Cancer Institute
Areas of expertise: Breast cancer, breast cancer surgery, cancer incidence, health care delivery, measuring quality of health care, health care outcomes

Opiod, Toxicology, Emergency Medicine

William Eggleston is originally from Binghamton, N.Y. and joins Binghamton University as a clinical assistant professor. He received his Doctor of Pharmacy degree from Wilkes University and completed a fellowship in clinical toxicology and emergency medicine at SUNY Upstate Medical University and with the Upstate New York Poison Center in Syracuse, N.Y. He comes to Binghamton from SUNY Upstate Medical University, where he served as an assistant professor in the Department of Emergency Medicine, and the Upstate New York Poison Center, where he worked as a clinical toxicologist. Eggleston is the director of the Opioid Research Center for Central New York (ORCC-NY), a multidisciplinary team of scientists, healthcare providers and community partners working to develop innovative ideas and strategies for treating and preventing the harms of opioid use disorder. Additionally, he is a member of the executive board of the New York State chapter of the American College of Clinical Pharmacy (ACCP).

Scotus, Supreme Court, criminal law, Constitution, Federal Courts

Epps is a nationally recognized expert on the Supreme Court. A former law clerk to Supreme Court Justice Anthony Kennedy, Epps focuses on criminal law and criminal procedure – and his scholarly approach draws upon history, philosophy, political science and economics. His research analyzes the criminal justice system using the tools and insights of structural public law and institutional design; he also researches and writes about constitutional theory and federal courts. His scholarship has appeared in the Harvard Law Review, the Yale Law Journal, the Michigan Law Review, and the NYU Law Review, and his writing for popular audiences has appeared in the New York Times Magazine, the Washington Post, Vox and The Atlantic.

Mark Esposito, PhD

Clinical Professor of Global Shifts and the Fourth Industrial Revolution

Thunderbird School of Global Management

Artificial Intelligence, Machine Learning, Business, technology and society, technology acceleration, Technology, Technological Entrepreneurship, Technology Transfer and Commercialization, Global Business, global business strategy, AI, Algorithms, Algorith

Dr. Mark Esposito is recognized internationally as a top global thought leader in matters relating to The Fourth Industrial Revolution, the changes and opportunities that technology will bring to industry.

Mark has held numerous senior positions at prestigious Institutes. He has been a member of the teaching faculty at Harvard University’s Division of Continuing Education where he has taught Economic Strategy and Competitiveness. He also has served as a Co-Leader at the Institutes Council for the Microeconomics of Competitiveness program (MOC) at Harvard Business School. 

Besides being a Professor at Thunderbird/ASU, Mark has been a Professor of Business & Economics at Hult International Business School, globally. 

He is an appointed Research Fellow in the Circular Economy Center, at the University of Cambridge's Judge Business School.

He is also a Fellow for the Mohammed Bin Rashid School of Government in Dubai.

Mark is the Co-Founder and Chief Learning Officer of Nexus Frontier Tech, an AI Studio, dedicated to the productions of AI solutions. 

He is a prolific author and his articles can be found on ResearchGate and his books on Amazon.

Mark serves as a global expert for the World Economic Forum.
He is the co-author of the best seller Understanding How the Future Unfolds: Using DRIVE to Harness the Power of Today's Megatrends. The framework contained therein was nominated for the CK Prahalad Breakthrough Idea Award by Thinkers50, the most prestigious award in business thought leadership.  His latest book, The AI Republic (2019) explores the nexus between humans and intelligent automation under the dome of the 4IR.

Mark holds a Ph.D. in Business and Economics from the International School of Management in Paris/ New York and an Executive Doctorate in Business Administration from Ecole des Ponts ParisTech in Paris. 

Areas of Expertise:
Fourth Industrial Revolution
Artificial Intelligence/Digital
Leading change
Economic Strategy
Growth and Competitive Strategy

Languages of Instruction:

Executive Doctorate of Business Administration, Ecole des Ponts Paris Tech
PhD in Business and Economics, International School of Management, Paris/New York
B.A and M.A in Social Sciences, University of Turin, Italy

Oncologist, Lymphoma (Hodgkin lymphoma and non-Hodgkin lymphoma), Blood Disorders, Blood Cancer, Leukemia, Hematology

Dr. Andrew M. Evens is a physician-scientist at the Rutgers Cancer Institute of New Jersey, where he is Associate Director for Clinical Services and Director of the Lymphoma Program. In addition, he is the Medical Director of the Oncology Service Line for the RWJBarnabas Health system. Dr. Evens completed a Hematology/Oncology fellowship at Northwestern University Feinberg School of Medicine and the Robert H. Lurie Comprehensive Cancer Center, where he was also Director of Translational Therapeutics. Prior to his Rutgers Cancer Institute appointment, Dr. Evens served as Chief of the Division of Hematology/Oncology at Tufts Medical Center and as Director of the Tufts Cancer Center in Boston, MA.

Dr. Evens is an associate editor for the British Journal of Haematology and serves on the editorial board for the Journal of Clinical Oncology. He is a core member of the Hodgkin Lymphoma Working Group for the NIH/NCI Steering Committee and has been a member of several clinical and scientific committees for the NIH, NCI, Cancer Therapy Evaluation Program (CTEP), Food and Drug Administration (FDA) and the ECOG/ACRIN group.  Dr. Evens is also an elected member of the Scientific Advisory Board for the Lymphoma Research Foundation (LRF) and he is involved in multiple national and international educational forums and events.

I completed a prior fellowship in hematology/oncology at Northwestern University Feinberg School of Medicine and the Robert H. Lurie Comprehensive Cancer Center in Chicago, Illinois, where I also remained as a faculty member altogether for 10 years. Most recently, I served as the director of the Cancer Center at Tufts Medical Center in Boston, chief of their division of hematology/oncology, and Professor of Medicine at Tufts University School of Medicine.

My clinical expertise and research interests are fully dedicated to the field of lymphoma (i.e., Hodgkin lymphoma and non-Hodgkin lymphoma). Over the past 15+ years, I have been the principal investigator of more than 80 national and international cancer clinical trials that have included phase I, II, and III studies, many which have been “investigator-initiated” trials studying new and novel targeted agents for the treatment of lymphoid malignancies. In addition to my clinical research, I also manage a translational laboratory studying the biology of lymphoma and to discover new and novel treatments for patients. Collectively, my research has been continuously funded by the National Institutes of Health (NIH) and the NCI since 2005. This has resulted in 200+ research abstracts at national and international cancer research symposiums, 150+ manuscripts in peer-reviewed publications, and 20+ book chapters all with an emphasis on the biology, prognosis, and treatment of lymphoma.

My involvement in the advancement of cancer research has also included leadership roles in academic journals, symposiums, cancer advocacy groups, and international committees. I was an associate editor for the British Journal of Haematology and on the editorial board for the Journal of Clinical Oncology and am the inaugural editor in chief for the open access journal, eJHaem. I am a core member of the Hodgkin Lymphoma Working Group for the NIH/NCI Steering Committee and I have been a member of several additional clinical and scientific committees for the NIH, NCI, Cancer Therapy Evaluation Program (CTEP), Food and Drug Administration (FDA) and the ECOG/ACRIN group. Furthermore, I am Co-Chair of the Lymphoma Committee for the ECOG-ACRIN cancer research group and am honored to be an elected member of the North American Scientific Advisory Board for the Lymphoma Research Foundation (LRF) and a member of the Board of Trustees for the Leukemia & Lymphoma Society (LLS) New Jersey Chapter. Finally, I am involved and help lead a multitude of regional, national, and international educational forums and events.

Associate Director for Clinical Services at Rutgers Cancer Institute of New Jersey
Medical Director of the Oncology Service Line, RWJBarnabas Health
Director, Lymphoma Program, Division of Blood Disorders

Clinical Expertise:
Hodgkin lymphoma, non-Hodgkin lymphoma (all types), chronic lymphocytic leukemia, and autologous hematopoietic stem cell (or bone marrow) transplantation.

Research Interests:
Lymphoma (Hodgkin lymphoma and non-Hodgkin lymphoma)
Chronic lymphocytic leukemia and other lymphoid malignancies
Clinical trials
Translational studies, including lymphoma biology and drug discovery
Systems biology and biomarker analyses
Lymphoma epidemiology
Health Outcomes, including Pharmacovigilance and Decision Making

I am thrilled to be a member of the Rutgers Cancer Institute of New Jersey (CINJ) as the Associate Director for Clinical Services, Medical Director of the Oncology Service Line for RWJBarnabas Health, and Director of the Lymphoma Program. Rutgers Cancer Institute is unique in that it is New Jersey’s only National Cancer Institute-designated Comprehensive Cancer Center. Our mission is to deliver integrated cancer care across the health system with access to academic expertise and innovative cancer therapies not available elsewhere in the state.

Advertising, Personal Data, Online behavioral advertising, Online Behavioral Marketing, Targeted Advertising

Before entering academia, Farman held several positions in the advertising industry. At Smiley360, she executed social media campaigns for popular consumer brands such as Country Crock, Schick, Staples and Florida's Natural Orange Juice. As an account supervisor on the IBM worldwide team at the advertising agency Ogilvy & Mather, she led advertising and direct marketing campaigns, managed clients and teams across six continents, and contributed to the development of the "Smarter Planet" campaign. She also worked at Market Maker Interactive, a web design agency, as a web copy writer and client manager for both consumer and business-to-business brands.

Farman has taught courses on Media Planning and Research & Statistics for Strategic Communication.

Neurosurgery, Glioblastoma, Brain Cancer, immunotheraphy, Cancer Vaccines

Chair of Neurosurgery, Roswell Park Cancer Institute
Areas of expertise: Neurosurgery, glioblastoma, brain cancer, immunotherapy, cancer vaccines

causal inference, Economics, Behavioral Economics, Behavioral Science, Environmental Policy, Johns Hopkins, Johns Hopkins Carey Business School

Paul J. Ferraro, PhD, is the Bloomberg Distinguished Professor of Business and Engineering at Johns Hopkins University. Dr. Ferraro has a joint faculty appointment in the Whiting School of Engineering and the Carey Business School. His research focuses on behavioral economics and the design and evaluation of environmental programs in the private and public sectors. Because these research areas are multi-disciplinary and applied, he collaborates with scientists and engineers from a variety of social, natural and physical science disciplines, as well as practitioners in the field.

Politics, Presidential Leadership, Puerto Rico, Immigration, Border Politics, race and politics, Religion And Politics, Citizenship, US citizenship

An assistant professor in the Department of Politics at Ithaca College’s School of Humanities and Sciences, Figueroa can discuss U.S. political issues, including presidential leadership, racial, religious and working class politics, U.S.-Puerto Rico policy, and immigration/border politics.

Figueroa’s academic research focuses on American political development; race, religion and citizenship; Black American politics and political thought; Latino politics and border studies; public leadership; and U.S. Quakers. He is currently finishing a book on Quakers, race and U.S. Empire. His research also focuses on Bayard Rustin, a Black, gay, Quaker labor and civil rights activist of the 1940s through 1980s. He is also working on a project about the everyday “lived experiences” of people who study and/or work near the U.S.-Mexico border.

Julie Fischer, PhD

Co-Director & Associate Research Professor

Georgetown University Medical Center


Associate research professor with the department of microbiology and a member of the Center for Global Health Science and Security at Georgetown University Medical Center. She focuses on research and tools to strengthen global capacities for public health preparedness and response. She has also worked on issues related to medical emergency preparedness, and the consequences of biological, chemical, and radiological exposures during military service. Fisher is a microbiologist by training and an expert in infectious diseases.

Global affairs, Management, Public Policy, global governance

Ann Florini is a Clinical Professor at the Thunderbird School of Global Management at Arizona State University, where she creates programs for the hub in Washington DC. She is faculty lead for Thunderbird's executive Master of Arts in Global Affairs and Management, a DC-based one-year professional masters launching in January 2020. For the 2018–2019 academic year she was Visiting Professor at the University of Maryland School of Public Policy. Until June 2018 she was Professor of Public Policy in the School of Social Sciences at Singapore Management University, where she was Academic Director of the Masters of Tri-Sector Collaboration, and was Non-resident Senior Fellow at the Brookings Institution in Washington, DC. Florini's academic training was at Syracuse University (BA, 1980), Princeton (Master's in Public Affairs, 1983) and at UCLA (Ph.D. in Political Science 1995). She was the founding director of the Centre on Asia and Globalisation at the National University of Singapore from 2006 to 2011. Prior to joining Brookings as a Senior Fellow in 2002, Florini was a senior associate at the Carnegie Endowment for International Peace, and from 1996 to 1997 she served as research director of the Rockefeller Brothers Fund Project on World Security. She was a senior researcher with the Center for International and Strategic Affairs at UCLA from 1987 to 1992, and from 1983 to 1987 she worked for the United Nations Association of the US, where she created and directed the Project on Multilateral Issues and Institutions.

Florini has spearheaded numerous international projects, including the Global Governance Initiative on behalf of the World Economic Forum (2000-2005) and the International Task Force on Transparency, Initiative for Policy Dialogue, Columbia University (2000-2005).

Elaine Fogel

speaker, marketer, brand and customer experience evangelist, copywriter, and president and CMO of Solutions Marketing

Solutions Marketing & Consulting LLC

Marketing, Consulting, Branding, Writing

Elaine has been a contributing writer to The Business Journal and MarketingProfs and currently contributes to SmallBizClub and Social Media Today. People in 100+ countries have read her blog, Totally Uncorked on Marketing, and her articles have appeared in many print and digital publications. She is also the author of Beyond Your Logo: 7 Brand Ideas That Matter Most For Small Business Success, a 2016 Finalist in the National Indie Excellence Awards as well as the Next Generation Indie Book Awards.

Elaine is the president and CMO of a boutique agency, Solutions Marketing & Consulting LLC, located in sunny Scottsdale, Arizona. She has worked with clients across the U.S. on marketing and branding strategy, marketing communications, and graphic design, while her husband and partner, Allen, manages promotional products and custom printing. 

Elaine is an entertaining speaker and trainer who’s passionate about sharing her expertise and watching the light bulbs go off. A Canadian-American who’s polite and candid, she brings over 20 years of marketing and branding experience to her audiences. Her high-energy, interactive approach keeps business and nonprofit groups on their toes!

Eric Forgoston

Professor of Applied Mathematics

Montclair State University

Applied Mathematics, Deterministic and Stochastic Dynamical Systems, mathematical biology, Fluid Mechanics, Mathematical Epidemiology

Eric Forgoston is an associate professor of applied mathematics at Montclair State University. His research involves the study of complex physical and biological phenomena, including material transport in the ocean, the outbreak and extinction of infectious diseases, behavior of biological and robotic swarms, food web dynamics in ecological systems, and the stability of fluid flows.

Katherine Foss, Ph.D.

Professor, Journalism and Strategic Media, College of Media and Entertainment

Middle Tennessee State University

Journalism and Strategic Media, media studies, Health Communication, Gender Studies

Katherine A. Foss (Ph.D., Mass Communication, University of Minnesota), is professor of Media Studies in the School of Journalism & Strategic Media at Middle Tennessee University and an award-winning scholar. Her research broadly examines facets of health communication, including the history of media and epidemics, breastfeeding discourse, and parasocial interactionism and grief. Previous studies have addressed children’s media literacy, gender and victimization, hearing loss, and other topics related to entertainment media.

She is the author of Constructing the Outbreak: Epidemics in Media and Collective Memory (University of Massachusetts Press, forthcoming), a book that encompasses more than 200 years of media coverage of epidemics. Past books also include Breastfeeding and Media: Exploring Conflicting Discourses That Threaten Public Health (2017, Palgrave Macmillan), and Television and Health Responsibility in an Age of Individualism (2014, Lexington Books). She has also produced more than two dozen publications that include op-eds, essays, reviews, book chapters, encyclopedia entries, and peer-reviewed articles in Journalism & Mass Communication Quarterly, Health Communication, Critical Studies in Media Communication, and other journals. Foss also served as the editor for The Graduate Student Guidebook: From Orientation to Tenure Track (forthcoming, Rowman & Littlefield), Beyond Princess Culture: Gender and Children’s Marketing (2019, Peter Lang Publishing) and Demystifying the Big House: Exploring Prison Experience and Media Representations (2018, Southern Illinois Press University). 

She serves as the on the Board of Directors for the Association of Education in Journalism & Mass Communication and on the editorial boards of Health Communication and the Image of the Journalist in Popular Culture. She was an invited speaker at the 2012 Great Nurse-In, a breastfeeding advocacy event held on the West Lawn of Capitol Hill in Washington, D.C. She also won the 2013 Covert Award and the 2012 James W. Carey Media Research Award and the for her co-authored article (with Dr. Kathy Forde) published in Book History.

Ian Foster, Ph.D.

Senior Scientist and Distinguished Fellow - Director of the Data Science and Learning Division, at Argonne National Laboratory - Arthur Holly Compton Distinguished Service Professor of Computer Science at the University of Chicago


Computer Science, data science, data-intensive computing technologies

Dr. Foster is Senior Scientist and Distinguished Fellow, and also director of the Data Science and Learning Division, at Argonne National Laboratory, and the Arthur Holly Compton Distinguished Service Professor of Computer Science at the University of Chicago. His research deals with distributed, parallel, and data-intensive computing technologies, and innovative applications of those technologies to scientific problems in such domains as materials science, climate change, and biomedicine. He is a fellow of the AAAS, ACM, BCS, and IEEE, and an Office of Science Distinguished Scientists Fellow. His awards include the BCS Lovelace Medal and IEEE Babbage and Kanai awards.

workplace power dynamics, Social Perception, interpersonal influence behaviors, Workplace Incivility, Organizational Behavior, Leadership

Dr. Trevor Foulk is an Assistant Professor of Management & Organization at the Robert H. Smith School of Business at the University of Maryland.  He received his Ph.D. in Organizational Behavior from the Warrington College of Business at the University of Florida, and his Bachelors of Business Administration from the University of Massachusetts.

Dr. Foulk’s research interests include deviant workplace behaviors, workplace power dynamics, social perception, and interpersonal influence behaviors.  His research has been published in the Academy of Management Journal, the Journal of Applied Psychology, the Journal of Organizational Behavior, Organizational Dynamics, and Pediatrics.  Dr. Foulk has contributed articles to Time Magazine, Harvard Business Review, and the USA Today, and his work has been featured in the Wall Street Journal, People Magazine, Scientific American, Fortune, The Huffington Post, New York Magazine, the Boston Globe, the LA Times, ABC News, and NBC News.

Epidemiology, Statistical Epidemiology, integrative biology

Spencer J. Fox is Associate Director of The University of Texas at Austin COVID-19 Modeling Consortium and a research associate at UT Austin. His expertise is in statistical modeling of infectious diseases and machine learning, and his research focuses on understanding emerging infectious diseases and pandemics, as well as developing response tools for public health officials. He earned his undergraduate degree in Biology at Rose-Hulman Institute of Technology and received a doctoral degree in Integrative Biology from the University of Texas at Austin in 2018, working with Professor Lauren Ancel Meyers. 


Fellowships & Awards

National Geographic Young Explorer (2017)

UT Austin recruitment fellowship (2013)

Ehlers-Danlos Syndrome, EDS, Skeletal Dysplasia, Hypermobility Spectrum Disorders

Dr. Clair Francomano has been involved in the care of individuals with the Ehlers-Danlos Syndromes throughout her career. During her years at the National Institutes of Health, she spear-headed a longitudinal study on the natural history of EDS that ran for over 20 years. She has served on the Steering Committee for the International Consortium on the Ehlers-Danlos Syndromes and Related Conditions and as chair of the Committee on Classical Ehlers-Danlos Syndrome for the Consortium since 2016.

Dr. Francomano joined Indiana University in August 2019 as professor of medical and molecular genetics at the IU School of Medicine and director of the Residency Training Program in Genetics at IU. Prior to joining IU, she was the director of the Ehlers-Danlos National Foundation Center for Clinical Care and Research at the Harvey Institute of Human Genetics, Greater Baltimore Medical Center, which she joined in 2005 as director of adult genetics

Dr. Francomano's research interests over the years have centered on hereditary disorders of connective tissue and skeletal dysplasias. In 1994, she became Chief of the Medical Genetics Branch at the National Human Genome Research Institute, National Institutes of Health, where she served as Clinical Director from 1996-2001. From 2001-2005 she was Chief of the Human Genetics and Integrative Medicine Section in the Laboratory of Genetics, National Institute on Aging. She has published over 130 peer-reviewed articles and lectures widely around the world about the Ehlers-Danlos Syndromes and related disorders. She has a keen interest in the management of the multiple co-morbidities seen in this condition.  

Dr. Francomano attended Yale College as an undergraduate and received her M.D. from Johns Hopkins University School of Medicine, where she trained in internal medicine and medical genetics. She joined the full-time Hopkins faculty in 1984.